Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin versus misoprostol for cervical ripening before hysteroscopy
IRCT20191123045476N4Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of nitroglycerin and misoprostol in Cervical insufficiency (CI) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Cervical dilatation. Started Jun 2023; status: completed.
02
Drugs
nitroglycerinmisoprostol
03
Conditions
Cervical insufficiency (CI)
Beyond the preview
Go deeper on IRCT20191123045476N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191123045476N4.